We are monitoring the impact of COVID-19 on APAC IVD Market Get in touch with us for detailed analysis Know More
Pulished Date August, 2019
ID: 124
Share on
Share on

Asia Pacific In-Vitro Diagnostics Market Research Report - By Product, By Technology, By Application & By Country(India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore and Rest of APAC)- Industry Analysis, Size, Share, Growth, Trends, Forecast | 2019 - 2024

Pulished: August, 2019
ID: 124
Pages: 145

APAC In-Vitro Diagnostics Market Size & Growth (2019 – 2024)

The market size of In-Vitro diagnostics in the Asia Pacific region has been estimated at USD 13.31 billion in 2019 and is poised to reach 18.15 billion in 2024 at a Compound Annual Growth Rate (CAGR) of 6.4%. Increasing population especially elderly people across the Asia Pacific region is a key driving factor for the market to grow.

In the Asia Pacific, there is a quiet increment in the scale of a number of diagnostics centers and hospitals which is straightly propelling the demand of the in-vitro diagnostics market. In-vitro diagnostics are very popular in giving accurate results in very little time where this is attracting many of the consumers. This attribute is expanding the size of the market to the extent. In addition, rising incidences of cancer and diabetes among many individuals is fuelling the growth rate of the market.

However, the cost of installation and maintenance of some equipment in laboratories is a bit expensive which is declining the growth rate of the market. Fluctuations in the prices of various raw materials required to manufacture the devices are also restraining the demand of the Asia Pacific in-vitro diagnostics market. Government authorities are very strict in approving new IVD products in concern towards people’s safety is remained as a challenging thing for the market developers. Lack of professionals in monitoring the systems is hampering the growth rate of the market in the Asia Pacific.

Increasing research on the development of new products with the latest technologies is creating chances for the market to grow. Rise in the investments from both public and private organizations to improve services in diagnostics centers is likely to outshine the demand of the market. Besides, growing demand for early diagnosis in most of the countries is leveling up the growth rate of the Asia Pacific in-vitro diagnostics market. Diagnosis of a disease is prior to having a proper and efficient treatment procedure and this greatly influencing the demand of the market eventually. Furthermore, escalating expenditure on healthcare in developed and developing countries is ascribed to bolster the growth rate of the market in this region.

This research report segmented and sub-segmented into the following categories:

  • By Product: Instruments, Reagents, Kits, Software
  • By Technology: Clinical Chemistry, Hematology, Immunoassays, Coagulation and Hemostasis, Molecular Diagnostics, Microbiology & other IVD technologies
  • By Application: Diabetes, Infectious, Oncology/Cancer, Cardiology, Nephrology, Autoimmune Diseases, Drug Testing, HIV

By Country: India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore and Rest of APAC

On the basis of geography, China Is the largest market for In-Vitro diagnostics accounting for a share of around XX% owing to the growing prevalence of chronic diseases such as cancer and respiratory diseases in the region while India is estimated to be the fastest-growing segment with a CAGR of XX%.

Noteworthy companies operating in the APAC IVD Market are Abbott Laboratories, Johnson and Johnson, Siemens Healthcare, Becton Dickinson, Roche Diagnostic, Beckman Coulter Inc., Biomérieux, Ortho Clinical Diagnostics, Inc., Bio-Rad Laboratories, Inc., Danaher Corporation, Sysmex Corporation and Thermo Fisher Scientific, Inc.

  1. Introduction

                1.1 Market Definition                                                                    

                1.2 Study Deliverables                                                                  

                1.3 Base Currency, Base Year and Forecast Periods                                                                           

                1.4 General Study Assumptions                                                                

  1. Research Methodology

                2.1 Introduction                                                                              

                2.2 Research Phases                                                                      

                                2.2.1 Secondary Research                                                            

                                2.2.2 Primary Research                                                 

                                2.2.3 Econometric Modelling                                                     

                                2.2.4 Expert Validation                                                  

                2.3 Analysis Design                                                                         

                2.4 Study Timeline                                                                          

  1. Overview

                3.1 Executive Summary                                                                

                3.2 Key Inferences                                                                         

                3.3 New Developments                                                                

  1. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)

                4.1 Market Drivers                                                                          

                4.2 Market Restraints                                                                    

                4.3 Key Challenges                                                                         

                4.4 Current Opportunities in the Market                                                               

  1. Market Segmentation

                5.1 By Product                                                                  

                                5.1.1 Instruments                                                           

                                5.1.2 Reagents and Kits                                                 

                                5.1.3 Software                                                 

                5.2 By Technology                                                                          

                                5.2.1 Clinical Chemistry                                                

                                5.2.2 Hematology                                                           

                                5.2.3 Immunoassays                                                      

                                5.2.4 Coagulation and Hemostasis                                                           

                                5.2.5 Molecular Diagnostics                                                        

                                5.2.6 Microbiology                                                          

                                5.2.7 Other IVD technologies                                                     

                5.3 By Application                                                                           

                                5.3.1 Diabetes                                                  

                                5.3.2 Infectious Diseases                                                             

                                5.3.3 Oncology/Cancer                                                 

                                5.3.4 Cardiology                                                               

                                5.3.5 Nephrology                                                            

                                5.3.6 Autoimmune Diseases                                                       

                                5.3.7 Drug Testing                                                           

                                5.3.8 HIV                                                             

  1. Geographical Analysis

                6.3 Asia-Pacific                                                                 

                                6.1 Introduction                                                              

                                6.2 China                                                            

                                6.3 India                                                              

                                6.4 Japan                                                            

                                6.5 South Korea                                               

  1. Strategic Analysis

                7.1 PESTLE analysis                                                                         

                                7.1.1 Political                                                     

                                7.1.2 Economic                                                 

                                7.1.3 Social                                                         

                                7.1.4 Technological                                                         

                                7.1.5 Legal                                                          

                                7.1.6 Environmental                                                      

                7.2 Porter’s Five analysis                                                                              

                                7.2.1 Bargaining Power of Suppliers                                                        

                                7.2.2 Bargaining Power of Consumers                                                    

                                7.2.3 Threat of New Entrants                                                     

                                7.2.4 Threat of Substitute Products and Services                                               

                                7.2.5 Competitive Rivalry within the Industry                                                      

  1. Market Leaders' Analysis

                8.1 Abbott Laboratories                                                               

                                8.1.1 Overview                                                

                                8.1.2 Product Analysis                                                   

                                8.1.3 Strategic Evaluation and Operations                                                            

                                8.1.4 Financial analysis                                                  

                                8.1.5 Legal issues                                                            

                                8.1.6 Recent Developments                                                       

                                8.1.7 SWOT analysis                                                       

                                8.1.8 Analyst View                                                          

                8.2 Johnson and Johnson                                                                             

                8.3 Siemens Healthcare                                                                

                8.4 Becton Dickinson                                                                     

                8.5 Roche Diagnostics                                                                    

                8.6 Beckman Coulter Inc.                                                                             

                8.7 Biomérieux                                                                

                8.8 Ortho Clinical Diagnostics, Inc.                                                                           

                8.9 Bio-Rad Laboratories, Inc.                                                                    

                8.10 Danaher Corporation                                                                           

                8.11 Sysmex Corporation                                                                             

                8.12 Thermo Fisher Scientific, Inc.                                                                            

  1. Competitive Landscape

                9.1 Market share analysis                                                                            

                9.2 Merger and Acquisition Analysis                                                                        

                9.3 Agreements, collaborations and Joint Ventures                                                                          

                9.4 New Product Launches                                                                          

  1. Expert Opinions

                10.1 Market Outlook                                                                     

                10.2 Investment Opportunities                                                                 

     Appendix                                                                                           

  1. List of Tables
  2. List of Figures
  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Asia-Pacific Global In-Vitro Diagnostics Market By Region, From 2019-2024 ( USD Billion )                                                               
  2. Asia-Pacific Global In-Vitro Diagnostics Market By Type, From 2019-2024 ( USD Billion )                                                   
  3. Asia-Pacific Instruments Market By Region, From 2019-2024 ( USD Billion )                                                           
  4. Asia-Pacific Reagents and Kits Market By Region, From 2019-2024 ( USD Billion )                                                
  5. Asia-Pacific Software Market By Region, From 2019-2024 ( USD Billion )                                                 
  6. Asia-Pacific Clinical Chemistry Market By Region, From 2019-2024 ( USD Billion )                                                
  7. Asia-Pacific Hematology Market By Region, From 2019-2024 ( USD Billion )                                                           
  8. Asia-Pacific Immunoassays Market By Region, From 2019-2024 ( USD Billion )                                                      
  9. Asia-Pacific Coagulation and Hemostasis Market By Region, From 2019-2024 ( USD Billion )                                                           
  10. Asia-Pacific Molecular Diagnostics Market By Region, From 2019-2024 ( USD Billion )                                                        
  11. Asia-Pacific Microbiology Market By Region, From 2019-2024 ( USD Billion )                                                         
  12. Asia-Pacific Other IVD technologies Market By Region, From 2019-2024 ( USD Billion )                                                     
  13. Asia-Pacific Diabetes Market By Region, From 2019-2024 ( USD Billion )                                                  
  14. Asia-Pacific Infectious Diseases Market By Region, From 2019-2024 ( USD Billion )                                                              
  15. Asia-Pacific Oncology/Cancer Market By Region, From 2019-2024 ( USD Billion )                                                 
  16. Asia-Pacific Cardiology Market By Region, From 2019-2024 ( USD Billion )                                                              
  17. Asia-Pacific Nephrology Market By Region, From 2019-2024 ( USD Billion )                                                            
  18. Asia-Pacific Autoimmune Diseases Market By Region, From 2019-2024 ( USD Billion )                                                       
  19. Asia-Pacific Drug Testing Market By Region, From 2019-2024 ( USD Billion )                                                          
  20. Asia-Pacific HIV Market By Region, From 2019-2024 ( USD Billion )                                                            
  21. China Market By Product, From 2019-2024 ( USD Billion )                                                              
  22. China Market By Technology, From 2019-2024 ( USD Billion )                                                       
  23. China Market By Application, From 2019-2024 ( USD Billion )                                                       
  24. India Market By Product, From 2019-2024 ( USD Billion )                                               
  25. India Market By Technology, From 2019-2024 ( USD Billion )                                                        
  26. India Market By Application, From 2019-2024 ( USD Billion )                                                        
  27. Japan Market By Product, From 2019-2024 ( USD Billion )                                                              
  28. Japan Market By Technology, From 2019-2024 ( USD Billion )                                                      
  29. Japan Market By Application, From 2019-2024 ( USD Billion )                                                       
  30. Rest Of Asia-Pacific Market By Product, From 2019-2024 ( USD Billion )                                                   
  31. Rest Of Asia-Pacific Market By Technology, From 2019-2024 ( USD Billion )                                                            
  32. Rest Of Asia-Pacific Market By Application, From 2019-2024 ( USD Billion )                                                            

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample